Fast-disintegrating sublingual epinephrine tablets: Effect of tablet dimensions on tablet characteristics

Drug Development and Industrial Pharmacy

Volumn 33, Issue 5, 2007, Pages 523-530

  Rawas Qalaji, Mutasem M ^a   Simons, F Estelle R ^b   Simons, Keith J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Anaphylaxis; Epinephrine; Fast disintegrating tablets; Sublingual

Indexed keywords

ADRENALIN;

ANAPHYLAXIS; ARTICLE; DRUG EFFECT; DRUG FORMULATION; FIRST AID;

ADMINISTRATION, SUBLINGUAL; ANAPHYLAXIS; CHEMISTRY, PHARMACEUTICAL; EPINEPHRINE; FIRST AID; HARDNESS; HUMANS; RHEOLOGY; SURFACE PROPERTIES; SYMPATHOMIMETICS; TABLETS; WETTABILITY;

EID: 34249318059     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600897150     Document Type: Article

References (26)

1. Allen, L. V. (2003). Rapid-dissolve technology: An interview with Lloyd v. Allen. IJPC, 7(6), 449-450.
2. Bi, Y., Sunada, H., Yonezawa, Y., & Danjo, K. (1999). Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev. Ind. Pharm., 25(5), 571-581.
3. Bi, Y., Sunada, H., Yonezawa, Y., Danjo, K., Otsuka, A., & Iida, K. (1996). Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharm. Bull., 44(11), 2121-2127.
4. Bredenberg, S., Duberg, M., Lennernas, B., Lennernas, H., Pettersson, A., Westerberg, M., et al. (2003). In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. Eur. J. Pharm. Sci., 20(3), 327-334.
5. Connors, K. A., Amidon, G. L., & Stella, V. J. (1986). Chemical stability of pharmaceuticals: A handbook for pharmacists (2nd Ed.). New York: Wiley-Interscience Publication.
6. Cunningham, F. E., Baughman, V. L., Peters, J., & Laurito, C. E. (1994). Comparative pharmacokinetics of oral versus sublingual clonidine. J. Clin. Anesth., 6(5), 430-433.
7. Fu, Y., Yang, S., Jeong, S. H., Kimura, S., & Park, K. (2004). Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies. Crit. Rev. Ther. Drug Carrier Syst., 21(6), 433-476.
8. Ishikawa, T., Mukai, B., Shiraishi, S., Utoguchi, N., Fujii, M., Matsumoto, M., et al. (2001). Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method. Chem. Pharm. Bull., 49(2), 134-139.
9. Kroboth, P. D., McAuley, J. W., Kroboth, F. J., Bertz, R. J., & Smith, R. B. (1995). Triazolam pharmacokinetics after intravenous, oral, and sublingual administration. J. Clin. Psychopharmacol., 15(4), 259-262.
10. Lefkowitz, R. J., Hoffman, B. B., & Taylor, P. (1996). Neurotransmission: The autonomic and somatic motor nervous systems. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon & A. G. Gilman (Eds.), Goodman & Gilman's the pharmacological basis of therapeutics (9 ed., pp. 105-139). New York: McGraw-Hill Companies, Inc.
11. Lieberman, P. (2003). Anaphylaxis and anaphylactoid reactions. In N. F. Adkinson, J. W. Yunginger, W. W. Busse, B. S. Bochner, S. T. Holgate & F. E. R. Simons (Eds.), Middleton's allergy: Principles and practice (6 ed., Vol. 2, pp. 1497-1522). St. Louis, Missouri: Mosby-Elsevier, Inc.
12. Marshall, K. (1986). Compression and consolidation of powdered solids. In L. Lachman, H. A. Lieberman & J. Kanig (Eds.), The theory and practice of industrial pharmacy (3 ed., pp. 66-99). Philadelphia: Lea & Febiger.
13. McLean-Tooke, A. P., Bethune, C. A., Fay, A. C., & Spickett, G. P. (2003). Adrenaline in the treatment of anaphylaxis: What is the evidence? BMJ, 327(7427), 1332-1335.
14. Price, T. M., Blauer, K. L., Hansen, M., Stanczyk, F., Lobo, R., & Bates, G. W. (1997). Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol. Obstet. Gynecol., 89(3), 340-345.
15. Rawas-Qalaji, M. M., Simons, F. E. R., & Simons, K. J. (2006a). Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis. J. Allergy Clin. Immunol., 117(2), 398-403.
16. Rawas-Qalaji, M. M., Simons, F. E. R., & Simons, K. J. (2006b). Fast-disintegrating sublingual tablets: Effect of epinephrine load on tablet characteristics. AAPS PharmSciTech., 7(2), Article 41.
17. Sampson, H. A., Munoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Jr., Bock, S. A., Branum, A., et al. (2006). Second symposium on the definition and management of anaphylaxis: Summary report-second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J. Allergy Clin. Immunol., 117(2), 391-397.
18. Sheth, B., Bandelin, F., & Shangraw, R. (1980). Compressed tablets. In H. Lieberman & L. Lachman (Eds.), Pharmaceutical dosage forms: Tablets (Vol. 1, pp. 109-185). New York, NY: Marcel Dekker, Inc.
19. Simons, F. E. R. (2004). First-aid treatment of anaphylaxis to food: Focus on epinephrine. J. Allergy Clin. Immunol., 113(5), 837-844.
20. Simons, K. J., Gu, X., & Simons, F. E. R. (2004). Sublingual epinephrine administration in humans: A preliminary study. J. Allergy Clin. Immunol., 113(2 Suppl), S260.
21. Sugimoto, M., Matsubara, K., Koida, Y., & Kobayashi, M. (2001). The preparation of rapidly disintegrating tablets in the mouth. Pharm. Dev. Technol., 6(4), 487-493.
22. USP/NF. (1990a). Official monographs: Nitroglycerin tablets (22/17 ed.). Rockville, MD: United States Pharmacopeial Convention, Inc.
23. USP/NF. (1990b). Physical tests: Disintegration (701) (22/17 ed.). Rockville, MD: United States Pharmacopeial Convention, Inc.
24. USP/NF. (2003). Physical tests: Uniformity of dosage units (905) (26/21 ed.). Rockville, MD: United States Pharmacopeial Convention, Inc.
25. Wadke, D. A., & Jacobson, H. (1980). Preformulation testing. In H. Lieberman & L. Lachman (Eds.), Pharmaceutical dosage forms: Tablets (Vol. 1, pp. 1-59). New York, NY: Marcel Dekker, Inc.
26. Watanabe, Y., Koizumi, K., Zama, Y., Kiriyama, M., Matsumoto, Y., & Matsumoto, M. (1995). New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol. Pharm. Bull., 18(9), 1308-1310.